Diabetes news are actually published almost every single day covering all factors of diabetes such as diabetes companies, illness, breakthroughs, research, medication and other vital information about the disease. Well, the daily diabetes news can serve as an encouragement and a source of diabetes niceties for diabetes patients.
This article seeks to publicize the following diabetes updates:-
- New Cut-Off Point Discovered
- Statins Users Are at Risk of getting Diabetes
- Afrezza for People with Type 1 Diabetes
- The Relationship between Diabetes and Cognitive Decline
- 50% of Adults Suffering From Type 2 Diabetes Worldwide Are Unaware Of the Condition.
- Type 2 Diabetes Drug Called Liraglutide Affects the Heart Rate Variably
- Medical Apps Could Boost Self-Managing of Diabetes.
New Cut-Off Point Discovered
The new cut-off point that has been discovered is basically recommended for diagnosing pre-diabetes. UK’s BMJ study reports that the new cut-off point is capable of defining whether someone has any kind of pre-diabetes or not. Pre-diabetes is the term used to describe the condition when someone is diagnosed with blood sugar levels that are near-characteristic of type 2 diabetes. The BMJ study suggests that health risks linked to pre-diabetes tend to worsen at lower cut-offs of blood sugar levels.
Statins Users Are At Risk of Getting Diabetes
Research shows that more than two thirds of the Americans population, comprising of majorly people who are aged 40 years and above, take statins. Statins are cholesterol lowering pills, which are used to reduce the risk of heart attack and stroke. They actually work by reducing the level of LDL cholesterol in blood. Yes they do reduce inflammation, but according to research they eventually lead to or worsen type 1 diabetes.
Afrezza for People with Type 1 Diabetes
According to Mannkind, the maker and marketer of inhaled insulin Afrezza, the success in re-launching of their product as a medication option not only depends on people’s fear of needles. He claims that the product is greatly effective, and has lots of clinical advantages over other types of insulin.
The Relationship between Diabetes and Cognitive Decline
Recent researches have it that people suffering from diabetes mellitus are at a higher risk of getting Cognitive decline. The study provides further evidences that the control and treatment of diabetes mellitus helps reduce the risk of contracting cognitive decline.
50% of Adults Suffering From Type 2 Diabetes Worldwide Are Unaware Of the Condition
IDF (International Diabetes Federation) recently held a global study and found out that there are lots patients who do not really know that they’ve got type 2 diabetes. According to the research, the unawareness is majorly as a result of lack of early screening. The research further indicates that approximately 46% of the world’s population comprises of diabetes patient who undiagnosed, so very few take medication.
Type 2 Diabetes Drug Called Liraglutide Affects the Heart Rate Variably
Liraglutide can actually affect the heart rate variably especially if taken by people who have heart problems or those who are overweight/obese. Liraglutide is basically a glucagon-like peptide marketed as Saxenda and Victoza. It is essentially a receptor agonist that reduces post-meal hyperglycemia and also helps control blood sugar levels.
Medical Apps Could Boost Self-Managing of Diabetes
A systematic review of reports provided by 14 study groups indicated that diabetes patients using health care apps recorded a considerable reduction in their blood sugar levels. They also reported an approximately 0.5% reduction in their glycated haemoglobin. This entails that the newly designed Medical Xpress app could be the answer to self-managing of diabetes.